Trends in Vaccine Coverage in North Carolina, 2011-2019
| Pediatric vaccines | Adolescent vaccines | General | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Year | DTaPa (24 mos) | DTaPb (K entry) | MMRa (24 mos) | MMRb (K entry) | Vaccine exemptionsc | Tdapd | MenACWYe | MMRf | HPVg | Fluh |
| 2011 | 94.5 (4.3) | NA | 93.7 (4.7) | NA | 0.2 | 77.8 (5.6) | 65.9 (6.3) | 89.4 (4.0) | 54.4 (9.8) | 46.5 |
| 2012 | 95.6 (2.8) | NA | 90.2 (4.9) | NA | 0.1 | 87.9 (4.5) | 68.2 (6.4) | 93.2 (3.2) | 53.3 (9.7) | 50.1 |
| 2013 | 92.1 (4.9) | NA | 91.5 (4.5) | NA | 0.1 | 89.4 (4.0) | 72.4 (5.7) | 87.1 (4.7) | 59.3 (9.5) | 51.0 |
| 2014 | 91.0 (5.5) | NA | 89.1 (5.6) | NA | 0.1 | 92.3 (3.7) | 74.1 (5.6) | 88.3 (4.3) | 71.1 (8.1) | 52.4 |
| 2015 | 95.6 (2.8) | 97.1 | 93.7 (3.4) | 97.3 | 0.1 | 93.4 (3.0) | 78.5 (5.1) | 91.5 (3.7) | 65.7 (8.5) | 50.9 |
| 2016 | 95.9 (2.7) | 96.1 | 92.1 (4.1) | 96.2 | 0.1 | 89.1 (4.0) | 75.7 (5.6) | 87.5 (4.6) | 57.5 (6.4) | 50.8 |
| 2017 | 92.1 (5.6) | 96.8 | 92.8 (4.9) | 97 | 0.2 | 91.9 (3.4) | 84.8 (4.8) | 93.0 (3.1) | 66.8 (6.1) | 46.0 |
| 2018 | NA | 93.2 | NA | 93.2 | 0.1 | 89.1 (4.1) | 86.1 (4.6) | 92.5 (3.5) | 68.6 (6.2) | 54.9 |
| 2019 | NA | 95.5 | NA | 95.5 | 0.1 | 92.0 (4.1) | 93.2 (3.8) | 94.3 (2.9) | 71.3 (6.5) | 55.8 |
Abbreviations. NA, Not available; DTaP, Diphtheria, Tetanus toxoid, acellular Pertussis; MMR, Measles, Mumps, Rubella; K, Kindergarten; Tdap, tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis; MenACWY, Meningococcal conjugate; HPV, Human Papillomavirus; mos, months.
↵a Childhood vaccination coverage among children 2 years old in NC, National Immunization Survey-Child (NIS-Child), birth years 2011 through 2017. Data shown for ≥3 doses of DTaP and ≥1 dose of MMR vaccine. Accessed on October 30, 2020 from https://www.cdc.gov/vaccines/imz-managers/coverage/childvaxview/interactive-reports/trend/index.html
↵b Estimated vaccination coverage among children enrolled in kindergarten in NC, School Vaccination Assessment Program, 2009-10 through 2019-20 school years. Accessed on January 25, 2021 from https://www.cdc.gov/vaccines/imz-managers/coverage/schoolvaxview/data-reports/coverage-trend/index.html
↵c Estimated number and percentage of children enrolled in kindergarten with an exemption from one or more vaccines in NC, School Vaccination Assessment Program, 2009-10 through 2019-20 school years. Accessed on January 25, 2021 from https://www.cdc.gov/vaccines/imz-managers/coverage/schoolvaxview/data-reports/exemptions-trend/index.html
↵d Tetanus-diphtheria toxoids (Td) or tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccination coverage among adolescents 13-17 years in NC, National Immunization Survey-Teen (NIS-Teen), 2011 through 2019. Values shown for ≥1 dose of Tdap vaccine. Accessed on October 30, 2020 from https://www.cdc.gov/vaccines/imz-managers/coverage/teenvaxview/data-reports/td-tdap/index.html
↵e Meningococcal conjugate (MenACWY) vaccination coverage among adolescents 13-17 years in NC, National Immunization Survey-Teen (NIS-Teen), 2011 through 2019. Values shown for ≥1 dose of MenACWY vaccine. Accessed on October 30, 2020 from https://www.cdc.gov/vaccines/imz-managers/coverage/teenvaxview/data-reports/menacwy/index.html
↵f Measles, mumps, and rubella (MMR) vaccination coverage among adolescents 13-17 years in NC, National Immunization Survey-Teen (NIS-Teen), 2011 through 2019. Values shown for ≥2 doses of MMR vaccine. Accessed on October 30, 2020 from https://www.cdc.gov/vaccines/imz-managers/coverage/teenvaxview/data-reports/mmr/index.html
↵g Human papillomavirus (HPV) vaccination coverage among adolescents 13-17 in NC, National Immunization Survey-Teen (NIS-Teen), 2011 through 2019. Data shown for ≥1 dose of the HPV vaccine (2011-15: females only; 2016-19: males and females). Accessed on October 30, 2020 from https://www.cdc.gov/vaccines/imz-managers/coverage/teenvaxview/data-reports/hpv/trend/index.html
↵h Seasonal influenza vaccination coverage estimates for persons 6 months and older in NC, National Immunization Survey-Flu (NIS-Flu) and Behavioral Risk Factor Surveillance System (BRFSS), 2010-11 through 2019-20 influenza seasons. Accessed on October 30, 2020 from https://www.cdc.gov/flu/fluvaxview/reportshtml/trends/index.html